News

Pradaxa (dabigatran etexilate) is Boehringer Ingelheim’s novel, oral direct thrombin inhibitor for stroke risk reduction in patients with non-valvular atrial fibrillation (AF). According to a statement, the Washington-based

The filing was accompanied by a priority review classification and a Prescription Drug User Fee Act (PDUFA) date of 17June, 2011. Apart from filing acceptance and assignment of

The patent also covers the polypeptide and nucleotide composition of matter for davunetide, its parent protein activity-dependent neuroprotective protein (ADNP) and other derivatives of ADNP. Currently, davunetide is

NU100 is a proprietary recombinant human interferon beta compound under development as a potential treatment for multiple sclerosis (MS) and will go into Phase III clinical trials in

The Phase II randomised clinical trial is designed to demonstrate the efficacy of adoptive cellular therapy for the pre-emptive treatment of cytomegalovirus (CMV) infections in patients who have

The ClinicalTrials.gov website is a registry of federally and privately supported clinical trials conducted in the US and around the world. The multi-centre, randomised, double-blind, placebo controlled Phase

Sodium thiopental is a sedative legally required for US lethal injections. In a statement, Novartis and Sandoz have said Sandoz has advised all its subsidiaries with locally approved

The trial is being conducted under the direction of James Cleary and George Cannon at the University of Wisconsin Carbone Cancer Center (UWCCC). ProCertus founder, chairman and chief

The study will assess tesetaxel as both first- and second-line chemotherapy. The study will evaluate two discrete populations: men with hormone/castrate-resistant prostate cancer, who have not previously received